Inivata Competitors and Similar CompaniesClear all
Inivata's competitors and similar companies include APEIRON Biologics, Veronomics, BioChain and Oncomine Molecular.
 Inivata Inivata is a clinical cancer genomics company focused on harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. |  APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. |  Veronomics Veronomics is a company developing a series of VeroTests in order to match drug susceptibilities to specific cancers. |  BioChain BioChain is a company offering biospecimens, tools for sample preparation analysis, and bio-assays. |  Oncomine Molecular Oncomine Molecular is a provider of next-generation sequencing (NGS) and genomic profiling for advancing cancer research and cancer patient outcomes. | |
Founding Date | Founding Date 2014 | Founding Date 2005 | Founding Date 2018 | Founding Date 1994 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Great Abington, GB HQ Babraham, GB Morrisville, US | Locations Wien, AT HQ | Locations HQ | Locations Newark, US HQ | Locations Waltham, US HQ |
Employees | Employees 363% decrease | Employees 5 | Employees 1 | Employees 395% decrease | Employees 6 |
For sources of this data, please see the company profile
View Company Profiles
APEIRON Biologics
HQ
Wien, AT
Employees
5
APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.
View companyVeronomics
HQ
Employees
1
Veronomics is a company developing a series of VeroTests in order to match drug susceptibilities to specific cancers.
View companyBioChain
HQ
Newark, US
BioChain is a company offering biospecimens, tools for sample preparation analysis, and bio-assays.
View companyOncomine Molecular
HQ
Waltham, US
Oncomine Molecular is a provider of next-generation sequencing (NGS) and genomic profiling for advancing cancer research and cancer patient outcomes.
View company